{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:44:28Z","timestamp":1770741868275,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ygyno.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T17:09:03Z","timestamp":1650647343000},"page":"522-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does the addition of radiation improve survival compared to chemotherapy alone in women with stage IV endometrial carcinoma? Analysis of the NCDB and SEER databases"],"prefix":"10.1016","volume":"165","author":[{"given":"David A.","family":"Barrington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Meade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Quick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley S.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2022.04.007_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2022.04.007_bb0010","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s12032-009-9389-3","article-title":"Clinical characteristics and outcomes of women with stage IV endometrial cancer","volume":"27","author":"Tanioka","year":"2010","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.04.007_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2004.02.008","article-title":"Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients","volume":"93","author":"Bruzzone","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.04.007_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Alvarez Secord","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.04.007_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygyno.2005.03.011","article-title":"Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study","volume":"97","author":"Sutton","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.04.007_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"24","author":"Randall","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.04.007_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2022.04.007_bb0040","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial Cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2022.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0360-3016(01)01566-8","article-title":"Significant pelvic recurrence in high-risk pathologic stage I\u2013IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy","volume":"50","author":"Mundt","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2022.04.007_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a gynecologic oncology group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"13","key":"10.1016\/j.ygyno.2022.04.007_bb0055","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer \u2013 results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2022.04.007_bb0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygyno.2014.05.002","article-title":"Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer","volume":"134","author":"Wilkinson-Ryan","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.04.007_bb0065","first-page":"2271","article-title":"Effect of postoperative sequential chemoradiotherapy and concurrent chemoradiotherapy in treating advanced endometrial cancer","volume":"25","author":"Chen","year":"2020","journal-title":"J. Buon"},{"issue":"4","key":"10.1016\/j.ygyno.2022.04.007_bb0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2013.08.014","article-title":"Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer","volume":"87","author":"Nagar","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.ygyno.2022.04.007_bb0075","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jamasurg.2018.0492","article-title":"Practical guide to surgical data sets: National Cancer Database (NCDB)","volume":"153","author":"Merkow","year":"2018","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2022.04.007_bb0080","series-title":"Number of Persons by Race and Hispanic Ethnicity for SEER Participants","author":"SEER","year":"2020"},{"issue":"12","key":"10.1016\/j.ygyno.2022.04.007_bb0085","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.clon.2016.06.009","article-title":"The impact of combined radiation and chemotherapy on outcome in uterine clear cell carcinoma compared with chemotherapy alone","volume":"28","author":"Mahdi","year":"2016","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"4","key":"10.1016\/j.ygyno.2022.04.007_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/IGC.0000000000000661","article-title":"Patterns of care, predictors, and outcomes of adjuvant therapy for early- and advanced-stage uterine clear cell carcinoma: a population-based analysis","volume":"26","author":"Gockley","year":"2016","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822002487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822002487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:33Z","timestamp":1758772833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822002487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0090825822002487"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.04.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the addition of radiation improve survival compared to chemotherapy alone in women with stage IV endometrial carcinoma? Analysis of the NCDB and SEER databases","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}